The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Methyl 3-O-(1H-benzo[d]imidazole-2-ylmethyl)-beta-D-galactopyranoside ID: ALA4870935
PubChem CID: 164622450
Max Phase: Preclinical
Molecular Formula: C15H20N2O6
Molecular Weight: 324.33
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CO[C@@H]1O[C@H](CO)[C@H](O)[C@H](OCc2nc3ccccc3[nH]2)[C@H]1O
Standard InChI: InChI=1S/C15H20N2O6/c1-21-15-13(20)14(12(19)10(6-18)23-15)22-7-11-16-8-4-2-3-5-9(8)17-11/h2-5,10,12-15,18-20H,6-7H2,1H3,(H,16,17)/t10-,12+,13-,14+,15-/m1/s1
Standard InChI Key: YDLARODXSABGKT-MYBUGEPTSA-N
Molfile:
RDKit 2D
23 25 0 0 0 0 0 0 0 0999 V2000
11.4462 -14.6629 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4462 -15.4879 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1582 -15.8963 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8703 -15.4879 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8703 -14.6629 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1582 -14.2463 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.1582 -16.7214 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.7323 -15.9015 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.5860 -14.2525 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.7305 -14.2525 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7281 -13.4275 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.5842 -15.9015 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.2993 -14.6672 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4437 -17.1339 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4437 -17.9589 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7806 -18.4463 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.1153 -18.4463 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.8605 -19.2310 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0386 -19.2308 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6292 -19.9414 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0406 -20.6527 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8658 -20.6489 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2714 -19.9378 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 6 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
3 7 1 1
2 8 1 1
5 9 1 1
1 10 1 1
10 11 1 0
4 12 1 6
9 13 1 0
7 14 1 0
14 15 1 0
15 16 2 0
16 19 1 0
18 17 1 0
17 15 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 324.33Molecular Weight (Monoisotopic): 324.1321AlogP: -0.47#Rotatable Bonds: 5Polar Surface Area: 117.06Molecular Species: NEUTRALHBA: 7HBD: 4#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 4#RO5 Violations (Lipinski): ┄CX Acidic pKa: 11.15CX Basic pKa: 4.77CX LogP: -0.56CX LogD: -0.56Aromatic Rings: 2Heavy Atoms: 23QED Weighted: 0.59Np Likeness Score: 0.79
References 1. Hassan M, van Klaveren S, Håkansson M, Diehl C, Kovačič R, Baussière F, Sundin AP, Dernovšek J, Walse B, Zetterberg F, Leffler H, Anderluh M, Tomašič T, Jakopin Ž, Nilsson UJ.. (2021) Benzimidazole-galactosides bind selectively to the Galectin-8 N-Terminal domain: Structure-based design and optimisation., 223 [PMID:34225180 ] [10.1016/j.ejmech.2021.113664 ]